Cosmon, Inc Raises $31.2M

Data Mission

We build purpose-driven tools that help cities and counties work smarter - from RFP creation and cost estimation to budgeting, workforce planning, and community insights. Our platform replaces spreadsheets and manual workflows with intelligent, transparent systems tailored to the complexities of local government. Whether you’re planning capital projects, managing procurement, or forecasting community needs, we give public agencies the clarity and confidence to lead with data.

SiteVue AI

Empowering the frontline worker with AI to drive automated continuous improvement while improving safety and employee engagement.

Aumet inc

Aumet is dedicated to providing tailored solutions that enhances the performance of healthcare providers, operating in Saudi Arabia, Jordan, Egypt and Oman It is a Saudi company that was Originally established in the United States, Aumet is now the largest B2B healthcare solution provider that supports companies with their business decisions and performance. Aumet facilitates the exchange of data between healthcare providers, manufacturers, and distributors to enable them to take the right decision.

Anagram Therapeutics, Inc.

Anagram is a clinical stage company leveraging proprietary enzyme technologies and expertise in gastrointestinal diseases to solve complex problems and advance a pipeline of products that can make a life-changing impact for people and their families living with cystic fibrosis and other rare diseases. Malabsorption syndromes and nutrient metabolism disorders prevent the body from properly processing or absorbing certain fats, sugars, proteins, vitamins or other key nutrients. ANG003, Anagram’s lead product is intended for the treatment of malabsorption and exocrine pancreatic insufficiency and is a new class of broad-spectrum digestive enzyme replacement therapy.

Pacific Hybreed

On a global scale, shellfish aquaculture provides a sustainable, low input source of healthy food. When practiced sustainably, shellfish farming can enhance water quality while providing habitat and other ecosystem services in the marine environment. Pacific Hybreed is the first commercial shellfish breeding company in the U.S. Our products offer both resilience, to mitigate the impact of threats to current production, and growth, through enhanced yield for producing Pacific oysters, Manila clams, Kumamoto oysters, and rock scallops, among other commercially important shellfish. Based on decades of university-based research by founders Dennis Hedgecock and Joth Davis, our technology responds to a changing global climate, warmer and more acidic oceans, and emerging diseases, including Pacific Oyster Mortality Syndrome (POMS), a viral disease that has devastated oyster production worldwide. Specifically, hybrid vigor, resulting from our crossbreeding program based on world class quantitative genomics, can enhance yield and resilience in shellfish, as it has in corn and other crops, without relying on genes from unrelated species (i.e., no GMOs). Our products will not interbreed with wild stocks.